IRIS Accounts Production v25.2.0.378 01800317 Board of Directors 1.7.24 30.6.25 30.6.25 Medium entities manufacture and sale of radiation measuring equipment for industry, medicine and research. true false true true false false true true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary Shares 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh018003172024-06-30018003172025-06-30018003172024-07-012025-06-30018003172023-06-30018003172023-07-012024-06-30018003172024-06-3001800317ns15:EnglandWales2024-07-012025-06-3001800317ns14:PoundSterling2024-07-012025-06-3001800317ns10:Director12024-07-012025-06-3001800317ns10:PrivateLimitedCompanyLtd2024-07-012025-06-3001800317ns10:MediumEntities2024-07-012025-06-3001800317ns10:Audited2024-07-012025-06-3001800317ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-07-012025-06-3001800317ns10:Medium-sizedCompaniesRegimeForAccounts2024-07-012025-06-3001800317ns10:FullAccounts2024-07-012025-06-3001800317ns10:OrdinaryShareClass22024-07-012025-06-3001800317ns10:Director22024-07-012025-06-3001800317ns10:Director32024-07-012025-06-3001800317ns10:Director42024-07-012025-06-3001800317ns10:RegisteredOffice2024-07-012025-06-3001800317ns5:RetainedEarningsAccumulatedLosses2024-06-3001800317ns5:RetainedEarningsAccumulatedLosses2023-06-3001800317ns5:RetainedEarningsAccumulatedLosses2024-07-012025-06-3001800317ns5:RetainedEarningsAccumulatedLosses2023-07-012024-06-3001800317ns5:RetainedEarningsAccumulatedLosses2025-06-3001800317ns5:RetainedEarningsAccumulatedLosses2024-06-3001800317ns5:CurrentFinancialInstruments2025-06-3001800317ns5:CurrentFinancialInstruments2024-06-3001800317ns5:ShareCapital2025-06-3001800317ns5:ShareCapital2024-06-3001800317ns5:SharePremium2025-06-3001800317ns5:SharePremium2024-06-3001800317ns5:CapitalRedemptionReserve2025-06-3001800317ns5:CapitalRedemptionReserve2024-06-3001800317ns15:UnitedKingdom2024-07-012025-06-3001800317ns15:UnitedKingdom2023-07-012024-06-3001800317ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-07-012025-06-3001800317ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-07-012024-06-3001800317ns10:HighestPaidDirector2024-07-012025-06-3001800317ns10:HighestPaidDirector2023-07-012024-06-3001800317ns10:HighestPaidDirector2025-06-3001800317ns10:HighestPaidDirector2024-06-3001800317ns5:OwnedAssets2024-07-012025-06-3001800317ns5:OwnedAssets2023-07-012024-06-3001800317ns10:OrdinaryShareClass22023-07-012024-06-3001800317ns5:LandBuildings2024-06-3001800317ns5:PlantMachinery2024-06-3001800317ns5:MotorVehicles2024-06-3001800317ns5:ComputerEquipment2024-06-3001800317ns5:LandBuildings2024-07-012025-06-3001800317ns5:PlantMachinery2024-07-012025-06-3001800317ns5:MotorVehicles2024-07-012025-06-3001800317ns5:ComputerEquipment2024-07-012025-06-3001800317ns5:LandBuildings2025-06-3001800317ns5:PlantMachinery2025-06-3001800317ns5:MotorVehicles2025-06-3001800317ns5:ComputerEquipment2025-06-3001800317ns5:LandBuildings2024-06-3001800317ns5:PlantMachinery2024-06-3001800317ns5:MotorVehicles2024-06-3001800317ns5:ComputerEquipment2024-06-3001800317ns5:WithinOneYearns5:CurrentFinancialInstruments2025-06-3001800317ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3001800317ns5:WithinOneYear2025-06-3001800317ns5:WithinOneYear2024-06-3001800317ns5:BetweenOneFiveYears2025-06-3001800317ns5:BetweenOneFiveYears2024-06-3001800317ns5:AllPeriods2025-06-3001800317ns5:AllPeriods2024-06-3001800317ns10:OrdinaryShareClass22025-06-3001800317ns5:SharePremium2024-06-3001800317ns5:CapitalRedemptionReserve2024-06-30
REGISTERED NUMBER: 01800317 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 June 2025

for

SOUTHERN SCIENTIFIC LIMITED

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)






Contents of the Financial Statements
for the Year Ended 30 June 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Statement of Income and Retained Earnings 9

Balance Sheet 10

Notes to the Financial Statements 11


SOUTHERN SCIENTIFIC LIMITED

Company Information
for the Year Ended 30 June 2025







DIRECTORS: R A Brown
M D Ford
S J Marshall
J P Tomlinson





REGISTERED OFFICE: Scientific House
Henfield Business Park
Shoreham Road
Henfield
West Sussex
BN5 9SL





REGISTERED NUMBER: 01800317 (England and Wales)





AUDITORS: Shorts Chartered Accountants
and Registered Auditor
2 Ashgate Road
Chesterfield
Derbyshire
S40 4AA

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Strategic Report
for the Year Ended 30 June 2025

The directors present their strategic report for Southern Scientific Limited ('the Company') for the year ended 30 June 2025.

REVIEW OF BUSINESS
The directors report that the market in which the business operates remains competitive in the current economic
climate, impacting on the margins achieved on many product lines and pre-tax profitability.

PRINCIPAL ACTIVITY
The principal activity of the company in the year of review was that of manufacture and sale of radiation measuring equipment for industry, medicine and research.

PRINCIPAL RISKS AND UNCERTAINTIES
Sales and Profit risk - the Company operates in a competitive market but retains a good market share and
continues to outperform some of its rivals. The Company's aim is to continue growing its turnover by introducing
new products and adding to existing ranges and services.

Credit Risk - the Company mainly deals with well-established organisations with little risk; where there is risk it
alters its payment terms so that the bulk of the debt is paid before delivery.

Liquidity Risk - the directors control and monitor the cash flow of the Company on a regular basis.

Foreign Exchange Rate Risk - the Company is not immune to changes in the global economic environment
and subsequent fluctuations in foreign exchange rates. The directors reduce foreign exchange rate risk by
holding funds in foreign exchange and chooses carefully when to transfer them to sterling.

EMPLOYEES
In order to meet its objectives it is essential that the Company recruits and retains the highest calibre of
employees at every level of the organisation. The employment policies of the Company embody the principles of
equal opportunity. The Company gives full and fair consideration to employment for disabled persons. If an
employee became disabled, arrangements would be made wherever practicable by identifying employment
suited to that person's capabilities and provided necessary retraining.

FINANCIAL KEY PERFORMANCE INDICATORS
The company's key performance indicators for the year are as follows:

Turnover - £9,239,594 (2024: £10,279,975)
Gross Profit - £4,092,593 (2024: £3,586,816)
Gross Margin - 44.3% (2024: 34.9%)
Profit before tax - £1,180,900 (2024: £665,716)

FUTURE DEVELOPMENTS AND FUTURE STRATEGY
The company continues to operate a sales strategy based on providing new model ranges and increasing and
improving existing model ranges. The company continues to review and improve the performance of its products
to ensure they remain one of the leading suppliers in the market. The company continues to look to increase its
geographical market share by trading in a large number of countries.

ON BEHALF OF THE BOARD:





J P Tomlinson - Director


10 December 2025

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Report of the Directors
for the Year Ended 30 June 2025

The directors present their report with the financial statements of the company for the year ended 30 June 2025.

DIVIDENDS
An interim dividend of 37.50 per share on the Ordinary Shares £0.01 shares was paid on 30 June 2025. The directors recommend that no final dividend be paid on these shares.

The total distribution of dividends for the year ended 30 June 2025 will be £ 3,000,000 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 July 2024 to the date of this report.

R A Brown
M D Ford
S J Marshall
J P Tomlinson

DIRECTORS' INDEMNITY PROVISIONS
The directors have been granted a qualifying third party indemnity provision under Section 234 of Companies Act 2006. This indemnity does not provide cover in the event of a director being proven to have acted fraudulently or dishonestly.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Report of the Directors
for the Year Ended 30 June 2025


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:




J P Tomlinson - Director


10 December 2025

Report of the Independent Auditors to the Members of
Southern Scientific Limited

Opinion
We have audited the financial statements of Southern Scientific Limited (the 'company') for the year ended 30 June 2025 which comprise the Statement of Income and Retained Earnings, Balance Sheet and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 June 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The other information comprises the information included in the Annual Report other than the financial statements and our Auditor’s Report thereon. The directors are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Southern Scientific Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Southern Scientific Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

- the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise
non-compliance with applicable laws and regulations;
- through discussions with the directors and other management and from our commercial knowledge and
experience of the sectors that the company operates in, we identified the laws and regulations applicable to the
company; and
- focusing on the specific laws and regulations including COSHH rules and regulations, which we considered may
have a direct material effect on the financial statements or the operations of the company, we assessed the extent
of compliance with those laws and regulations identified above through making enquiries of management and
inspecting relevant correspondence.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge
of actual, suspected and alleged fraud; and
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

- performed analytical procedures to identify any unusual or unexpected relationships;
- considered journal entries to identify unusual transactions;
- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of
potential bias; and
- investigated the rationale behind significant or unusual transactions.
- performed substantive testing of a random sample of income and expenditure.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

- agreeing financial statement disclosures to underlying supporting documentation;
- enquiring of management as to actual and potential litigation and claims; and
- reviewing any correspondence with HMRC, relevant regulators and the company’s legal advisors.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to
enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.


Report of the Independent Auditors to the Members of
Southern Scientific Limited

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may
involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Howard Freeman BSc FCA (Senior Statutory Auditor)
For and on behalf of Shorts Chartered Accountants
and Registered Auditor
2 Ashgate Road
Chesterfield
Derbyshire
S40 4AA

10 December 2025

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Statement of Income and Retained Earnings
for the Year Ended 30 June 2025

30.6.25 30.6.24
Notes £    £    £    £   

TURNOVER 3 9,239,594 10,279,975

Other operating income 60,125 -
9,299,719 10,279,975

Raw materials and consumables 5,147,001 6,693,159
4,152,718 3,586,816

Staff costs 4 1,813,903 1,802,864
Depreciation 104,195 87,298
Other operating expenses 1,101,002 1,097,804
3,019,100 2,987,966
OPERATING PROFIT 5 1,133,618 598,850

Interest receivable and similar income 47,282 66,866
PROFIT BEFORE TAXATION 1,180,900 665,716

Tax on profit 6 323,400 63,450
PROFIT FOR THE FINANCIAL YEAR 857,500 602,266

Retained earnings at beginning of year 3,293,003 2,690,737

Dividends 7 (3,000,000 ) -

RETAINED EARNINGS AT END OF YEAR 1,150,503 3,293,003

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Balance Sheet
30 June 2025

30.6.25 30.6.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 8 480,972 498,977

CURRENT ASSETS
Stocks 9 448,211 620,200
Debtors 10 2,334,236 1,278,463
Cash at bank 2,247,059 5,141,065
5,029,506 7,039,728
CREDITORS
Amounts falling due within one year 11 2,777,056 2,680,661
NET CURRENT ASSETS 2,252,450 4,359,067
TOTAL ASSETS LESS CURRENT LIABILITIES 2,733,422 4,858,044

ACCRUALS AND DEFERRED INCOME 13 1,546,969 1,529,091
NET ASSETS 1,186,453 3,328,953

CAPITAL AND RESERVES
Called up share capital 14 800 800
Share premium 15 34,950 34,950
Capital redemption reserve 15 200 200
Retained earnings 15 1,150,503 3,293,003
SHAREHOLDERS' FUNDS 1,186,453 3,328,953

The financial statements were approved by the Board of Directors and authorised for issue on 10 December 2025 and were signed on its behalf by:





J P Tomlinson - Director


SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements
for the Year Ended 30 June 2025

1. STATUTORY INFORMATION

Southern Scientific Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

Principal activity
The principal activity of the company in the year under review was that of manufacture and sale of radiation measuring equipment for industry, medicine and research.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102)" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows;
the requirement of paragraph 33.7.

This information is included in the consolidated financial statements of Paradigm Holdingco Limited as at 30 June 2025 and these financial statements may be obtained from Companies House.

Revenue recognition
Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods
Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

- the Company has transferred the significant risks and rewards of ownership to the buyer;
- the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the transaction; and
- the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services
Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following bases:

Land and buildings 2 %
Plant and equipment 25 %
Computer equipment25 %
Motor vehicles25 %

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Taxation
Tax is recognised in the Statement of Income and Retained Earnings.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but no reversed by the Balance Sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits ; and

- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences.

Research and development
Expenditure on research and development is recognised in the year in which it is incurred.

Research and development expenditure credit ('RDEC') is recognised as other income in profit or loss.

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

2. ACCOUNTING POLICIES - continued

Foreign currencies
The company's functional and presentational currency is pounds sterling.

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions and foreign currency balances at the each period end are translated into the presentation currency using the closing rate.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Operating leases
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account on a straight line basis over the period of the lease.

Provisions for liabilities
Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.

Increases in provisions are generally charged as an expense to profit or loss.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

30.6.25 30.6.24
£    £   
United Kingdom 7,800,323 9,319,818
Rest of Europe 785,585 383,078
Rest of the world 653,686 577,079
9,239,594 10,279,975

4. EMPLOYEES AND DIRECTORS
30.6.25 30.6.24
£    £   
Wages and salaries 1,574,868 1,572,416
Social security costs 187,334 192,448
Other pension costs 51,701 38,000
1,813,903 1,802,864

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

4. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
30.6.25 30.6.24

Management and administration 13 13
Production and quality 10 8
Sales, service and support 7 7
30 28

30.6.25 30.6.24
£    £   
Directors' remuneration 318,878 487,652
Directors' excess retirement benefits 58,880 13,680

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 3 3

Information regarding the highest paid director is as follows:
30.6.25 30.6.24
£    £   
Emoluments etc 158,040 325,304
Accrued pension at 30 June 2025 51,400 6,400

5. OPERATING PROFIT

The operating profit is stated after charging:

30.6.25 30.6.24
£    £   
Depreciation - owned assets 104,032 86,929
Loss on disposal of fixed assets 163 369
Auditors' remuneration 12,000 9,000

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
30.6.25 30.6.24
£    £   
Current tax:
UK corporation tax 323,400 63,450
Tax on profit 323,400 63,450

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

30.6.25 30.6.24
£    £   
Profit before tax 1,180,900 665,716
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

295,225

166,429

Effects of:
Expenses not deductible for tax purposes 3,389 386
Capital allowances in excess of depreciation - (45,546 )
Depreciation in excess of capital allowances 11,210 -
Accrued employers pension contributions 13,576 -
Research and development enhanced deduction - (57,819 )
Total tax charge 323,400 63,450

7. DIVIDENDS
30.6.25 30.6.24
£    £   
Ordinary Shares shares of £0.01 each
Interim 3,000,000 -

8. TANGIBLE FIXED ASSETS
Leasehold Plant and Motor Computer
property machinery vehicles equipment Totals
£    £    £    £    £   
COST
At 1 July 2024 265,233 123,496 233,505 170,136 792,370
Additions - 6,890 74,500 6,475 87,865
Disposals - - - (2,595 ) (2,595 )
At 30 June 2025 265,233 130,386 308,005 174,016 877,640
DEPRECIATION
At 1 July 2024 5,337 68,504 110,155 109,397 293,393
Charge for year 5,304 20,111 48,257 30,360 104,032
Eliminated on disposal - - - (757 ) (757 )
At 30 June 2025 10,641 88,615 158,412 139,000 396,668
NET BOOK VALUE
At 30 June 2025 254,592 41,771 149,593 35,016 480,972
At 30 June 2024 259,896 54,992 123,350 60,739 498,977

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

9. STOCKS
30.6.25 30.6.24
£    £   
Stock and work in progress 448,211 620,200

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.25 30.6.24
£    £   
Trade debtors 2,087,975 959,782
Amounts owed by group undertakings 127,838 98,347
Other debtors 67,229 190,441
Prepayments 51,194 29,893
2,334,236 1,278,463

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.25 30.6.24
£    £   
Trade creditors 371,432 273,632
Amounts owed to group undertakings 1,001,191 564,280
Corporation tax 223,275 63,450
Paye and national insurance 61,299 52,555
Value added tax 448,183 364,577
Other creditors 363,368 1,102,691
Accrued expenses 308,308 259,476
2,777,056 2,680,661

12. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.6.25 30.6.24
£    £   
Within one year 22,000 -
Between one and five years 25,667 -
47,667 -

13. ACCRUALS AND DEFERRED INCOME
30.6.25 30.6.24
£    £   
Warranties 583,329 691,105
Deferred income 963,640 837,986
1,546,969 1,529,091

SOUTHERN SCIENTIFIC LIMITED (REGISTERED NUMBER: 01800317)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

14. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.25 30.6.24
value: £    £   
80,000 Ordinary Shares £0.01 800 800

15. RESERVES
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 July 2024 3,293,003 34,950 200 3,328,153
Profit for the year 857,500 857,500
Dividends (3,000,000 ) (3,000,000 )
At 30 June 2025 1,150,503 34,950 200 1,185,653

Retained earnings

The retained earnings represents all current and prior retained profits and losses and is all considered to be distributable.

Share premium

The share premium account represents the excess amount received over the nominal value of shares issued, and is considered non-distributable.

Capital redemption reserve

The capital redemption reserve represents the nominal value of shares repurchased and cancelled by the Company.

16. RELATED PARTY DISCLOSURES

The Company has taken advantage of the exemption in FRS 102 Section 33.1A to not disclose transactions with wholly owned group entities.

In respect of other companies within the Group that are not wholly owned, the Company made sales of £573,973 (2024: £519,883) to Lablogic Systems Inc during the year. As at 30 June 2025 £nil (2024: £nil) was due to the company.

17. CONTROLLING PARTY

The immediate parent Company is Lablogic Group Holdings Limited, whose registered office address is
Innovation House, 6 Europa View, Sheffield, South Yorkshire, England, S9 1XH.

From 29 May 2024, the ultimate parent Company is Paradigm Holdingco Limited, whose registered office
is Innovation House, 6 Europa View, Sheffield, South Yorkshire, England, S9 1XH.The group financial
statements of Paradigm Holdingco Limited, are publicly available from Companies House.